These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33501563)

  • 41. Vaginal pessaries for treatment of pelvic organ prolapse in elderly women.
    Griebling TL
    Curr Opin Urol; 2016 Mar; 26(2):201-6. PubMed ID: 26765048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolapse surgery versus vaginal pessary in women with symptomatic pelvic organ prolapse: which factors influence the choice of treatment?
    Bodner-Adler B; Bodner K; Stinglmeier A; Kimberger O; Halpern K; Koelbl H; Umek W
    Arch Gynecol Obstet; 2019 Mar; 299(3):773-777. PubMed ID: 30656443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse.
    Fernando RJ; Thakar R; Sultan AH; Shah SM; Jones PW
    Obstet Gynecol; 2006 Jul; 108(1):93-9. PubMed ID: 16816061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of pessary treatment on puborectalis muscle function.
    Manzini C; van den Noort F; Grob ATM; Withagen MIJ; van der Vaart CH
    Int Urogynecol J; 2021 Jun; 32(6):1409-1417. PubMed ID: 33847771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors for dislodgment of vaginal pessary within one year in women with pelvic organ prolapse.
    Cheung RYK; Lee LLL; Chung TKH; Chan SSC
    Maturitas; 2018 Feb; 108():53-57. PubMed ID: 29290215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaginal Pessaries for Pelvic Organ Prolapse and Their Impact on Sexual Function.
    Rantell A
    Sex Med Rev; 2019 Oct; 7(4):597-603. PubMed ID: 31378507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial.
    Hagen S; Kearney R; Goodman K; Melone L; Elders A; Manoukian S; Agur W; Best C; Breeman S; Dembinsky M; Dwyer L; Forrest M; Graham M; Guerrero K; Hemming C; Khunda A; Mason H; McClurg D; Norrie J; Karachalia-Sandri A; Thakar R; Bugge C
    Trials; 2020 Oct; 21(1):837. PubMed ID: 33032644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Use of a Vaginal Pessary to Decide Whether a Mid Urethral Sling should be Added to Prolapse Surgery.
    Goessens E; Deriemaeker H; Cammu H
    J Urol; 2020 Mar; 203(3):598-603. PubMed ID: 31584852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness and cost-effectiveness of pessary treatment compared with pelvic floor muscle training in older women with pelvic organ prolapse: 2-year follow-up of a randomized controlled trial in primary care.
    Panman CM; Wiegersma M; Kollen BJ; Berger MY; Lisman-van Leeuwen Y; Vermeulen KM; Dekker JH
    Menopause; 2016 Dec; 23(12):1307-1318. PubMed ID: 27504918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pelvic floor muscle training versus watchful waiting or pessary treatment for pelvic organ prolapse (POPPS): design and participant baseline characteristics of two parallel pragmatic randomized controlled trials in primary care.
    Wiegersma M; Panman CM; Kollen BJ; Vermeulen KM; Schram AJ; Messelink EJ; Berger MY; Lisman-Van Leeuwen Y; Dekker JH
    Maturitas; 2014 Feb; 77(2):168-73. PubMed ID: 24268876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Guideline No. 411: Vaginal Pessary Use.
    Harvey MA; Lemieux MC; Robert M; Schulz JA
    J Obstet Gynaecol Can; 2021 Feb; 43(2):255-266.e1. PubMed ID: 33248302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How often should ring pessaries be removed or changed in women with advanced POP? A prospective observational study.
    Miceli A; Fernández-Sánchez M; Dueñas-Díez JL
    Int Urogynecol J; 2021 Jun; 32(6):1471-1478. PubMed ID: 33620536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse.
    Lone F; Thakar R; Sultan AH; Karamalis G
    Int J Gynaecol Obstet; 2011 Jul; 114(1):56-9. PubMed ID: 21575953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse.
    Barber MD; Walters MD; Cundiff GW;
    Am J Obstet Gynecol; 2006 May; 194(5):1492-8. PubMed ID: 16647933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life in women who use pessaries for longer than 12 months.
    Tenfelde S; Tell D; Thomas TN; Kenton K
    Female Pelvic Med Reconstr Surg; 2015; 21(3):146-9. PubMed ID: 25521465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term effectiveness of transvaginal high uterosacral ligament suspension].
    Duan L; Lu YX; Shen WJ; Liu X; Liu JX; Zhang YH; Ge J; Zhao Y; Niu K; Wang WY
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):363-368. PubMed ID: 28647957
    [No Abstract]   [Full Text] [Related]  

  • 57. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaginal pessary continuation in symptomatic pelvic organ prolapse patients with prior hysterectomy.
    Ma C; Kang J; Xu T; Zhang Y; Ma Y; Liang S; Hui Y; Wang Y; Zhu L
    Menopause; 2020 Oct; 27(10):1148-1154. PubMed ID: 32881830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery.
    Coolen AWM; Troost S; Mol BWJ; Roovers JPWR; Bongers MY
    Int Urogynecol J; 2018 Jan; 29(1):99-107. PubMed ID: 28600758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.